EUVIMEDEUVIMED entdecken
Crossref

Ultradiluted Homeopathic Medicines Cause Apoptosis in RPMI-8226 Multiple Myeloma Cells in vitro: a Pilot Study

Buket Altinok Gunes iD, Murat Kilic iD, Tulin Ozkan iD, Nurbanu Gonulkirmaz iD, Nurcihan Guven iD, Asuman Sunguroglu iD

Homeopathy · 01.02.2025 · 114 (01) · 044-049

DOI: 10.1055/s-0044-1786035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Homeopathy, erschienen am 01.02.2025. Verfasst von Buket Altinok Gunes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Vocational School of Health Services, Ankara University, Ankara, Turkey. Hauptthemen laut MEDLINE: Multiple Myeloma, Apoptosis, Homeopathy, Materia Medica. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multiple myeloma (MM) is the second most common type of cancer among hematological malignancies and is difficult to treat. Although controversial in nature, homeopathy's effects have been tested on a wide range of cancer cell types in vitro, as well as clinically. However, homeopathic medicines have yet to be tested in MM cells. In this preliminary study, we investigated the effects of Arsenicum album, Hecla lava, Carcinosinum and Carboneum sulphuratum 200C on a human MM cell line.

Methods

The RPMI-8226 MM cell line was cultured in vitro for up to 96 hours and treated with each of four homeopathic preparations. The spectrophotometric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, flow cytometric Annexin V-PE/7-actinomycin D (7-AAD) and propidium iodide (PI) staining were each used to examine cell viability, apoptosis and cell cycle, respectively.

Results

The MTT assay showed that all four homeopathic preparations reduced cell viability over time when compared to the control group cells, especially at 72 and 96 hours whereby only 50% of cells remained viable. Similarly, after 96 hours of treatment, the proportion of viable cells was significantly decreased and the proportion of early apoptotic (Annexin-V-PE +/7AAD-) cells was significantly increased for all four homeopathic preparations. Based on the PI-staining cell cycle data, cells treated with Hecla lava and Carboneum sulphuratum showed a statistically significant accumulation in the sub-G0/G1 phase of the cell cycle (p < 0.05).

Conclusion

This is the first study to demonstrate that each of four homeopathic medicines causes apoptosis in a MM cell line. Further exploration of the potential of Arsenicum album, Hecla lava, Carcinosinum and Carboneum sulphuratum as a complementary therapeutic option in MM is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaApoptosisHomeopathyMateria MedicaPlant ExtractsHumansPilot ProjectsCell Line, TumorCell Survival

Substanzen

Materia MedicaPlant Extracts

Autor:innen und Institutionen

  • Vocational School of Health Services, Ankara University, Ankara, Turkey.
  • Department of Medical Biology, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Department of Pharmacognosy, Faculty of Pharmacy, Anadolu University, Eskisehir, Turkey.

ORCID-Profile: Buket Altinok Gunes, Murat Kilic, Tulin Ozkan, Nurbanu Gonulkirmaz, Nurcihan Guven, Asuman Sunguroglu

Zitieren

APA

Altinok Gunes, B., Kilic, M., Ozkan, T., Gonulkirmaz, N., Guven, N., & Sunguroglu, A. (2025). Ultradiluted Homeopathic Medicines Cause Apoptosis in RPMI-8226 Multiple Myeloma Cells in vitro: a Pilot Study. Homeopathy, 114(01), 044-049. https://doi.org/10.1055/s-0044-1786035

Vancouver

Altinok Gunes B, Kilic M, Ozkan T, Gonulkirmaz N, Guven N, Sunguroglu A. Ultradiluted Homeopathic Medicines Cause Apoptosis in RPMI-8226 Multiple Myeloma Cells in vitro: a Pilot Study. Homeopathy. 2025;114(01):044-049. doi:10.1055/s-0044-1786035

BibTeX
@article{AltinokGunes2025,
  author = {Altinok Gunes, Buket and Kilic, Murat and Ozkan, Tulin and Gonulkirmaz, Nurbanu and Guven, Nurcihan and Sunguroglu, Asuman},
  title = {Ultradiluted Homeopathic Medicines Cause Apoptosis in RPMI-8226 Multiple Myeloma Cells in vitro: a Pilot Study},
  journal = {Homeopathy},
  year = {2025},
  volume = {114},
  number = {01},
  pages = {044--049},
  doi = {10.1055/s-0044-1786035}
}
Kostenlos starten →